DS-8273

N/A

Report date: 2026/01/02 20:01:19

Base Information

Drug NameDS-8273
Drug Alias NameAnti-DR5 monoclonal antibodyDS-8273DS-8273a
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 10B agonists
TargetsTumor necrosis factor receptor superfamily member 10B
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsMelanoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursColorectal NeoplasmsMelanoma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A